Literature DB >> 11311125

Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation.

A Poliakov1, V Tkachuk, T Ovchinnikova, N Potapenko, S Bagryantsev, V Stepanova.   

Abstract

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) act in concert to mediate pericellular proteolysis and to stimulate intracellular signalling responsible for cell migration and proliferation. uPA is composed of three domains, a proteolytic domain (PD), a kringle domain (KD) and a growth-factor-like domain (GFD), the last of which mediates the interaction with uPAR. We demonstrate that uPA, associated with the surface of U937 cells, undergoes plasmin-mediated cleavage of the Lys(46)-Ser(47) bond with elimination of the GFD. Using recombinant forms of uPA, we show that a uPA variant lacking the GFD (r-uPADeltaGFD) and unable to associate with uPAR is rapidly cleared from the cell surface. Binding and internalization of r-uPADeltaGFD are markedly decreased in the presence of 39 kDa receptor-associated protein (RAP), the antagonist of several endocytic receptors of the low-density lipoprotein receptor family, suggesting that this protein clearance pathway is used for r-uPADeltaGFD. In contrast with rapidly internalized r-uPADeltaGFD, the intact recombinant single-chain urokinase with wild-type structure (r-uPAwt) bound to uPAR is retained on the cell surface. Soluble uPAR protects uPA from cleavage by plasmin that results in the elimination of GFD, suggesting that uPAR might protect cell-bound urokinase from plasmin-mediated cleavage between the GFD and KD and subsequent degradation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311125      PMCID: PMC1221778          DOI: 10.1042/bj3550639

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains.

Authors:  A A Poliakov; S A Mukhina; D O Traktouev; R S Bibilashvily; Y G Gursky; M M Minashkin; V V Stepanova; V A Tkachuk
Journal:  J Recept Signal Transduct Res       Date:  1999-11       Impact factor: 2.092

2.  Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores.

Authors:  S P Christow; R Bychkov; C Schroeder; R Dietz; H Haller; I Dumler; D C Gulba
Journal:  Eur J Biochem       Date:  1999-10-01

3.  Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.

Authors:  M Yebra; L Goretzki; M Pfeifer; B M Mueller
Journal:  Exp Cell Res       Date:  1999-07-10       Impact factor: 3.905

4.  Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells.

Authors:  G J Bhat; J J Gunaje; S Idell
Journal:  Am J Physiol       Date:  1999-08

5.  Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells.

Authors:  I Dumler; A Kopmann; A Weis; O A Mayboroda; K Wagner; D C Gulba; H Haller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-02       Impact factor: 8.311

6.  Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.

Authors:  H Kobayashi; J Gotoh; Y Hirashima; M Fujie; D Sugino; T Terao
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

7.  The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds.

Authors:  J Rømer; L R Lund; J Eriksen; C Pyke; P Kristensen; K Danø
Journal:  J Invest Dermatol       Date:  1994-04       Impact factor: 8.551

8.  Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.

Authors:  A Nykjaer; L Kjøller; R L Cohen; D A Lawrence; B A Garni-Wagner; R F Todd; A J van Zonneveld; J Gliemann; P A Andreasen
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

Review 9.  The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.

Authors:  N Behrendt; E Rønne; K Danø
Journal:  Biol Chem Hoppe Seyler       Date:  1995-05

10.  Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro.

Authors:  S S Okada; J E Tomaszewski; E S Barnathan
Journal:  Exp Cell Res       Date:  1995-03       Impact factor: 3.905

View more
  6 in total

1.  Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.

Authors:  Alexander Kapustin; Victoria Stepanova; Natalia Aniol; Douglas B Cines; Alexei Poliakov; Serge Yarovoi; Tatiana Lebedeva; Robin Wait; Grigory Ryzhakov; Yelena Parfyonova; Yaroslav Gursky; Hiromi Yanagisawa; Mikhail Minashkin; Robert Beabealashvilli; Alexander Vorotnikov; Alex Bobik; Vsevolod Tkachuk
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

2.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Authors:  Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew Mazar; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

Review 3.  Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.

Authors:  Rais Reskiawan A Kadir; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2019-09-24       Impact factor: 5.046

4.  Nuclear translocation of urokinase-type plasminogen activator.

Authors:  Victoria Stepanova; Tatiana Lebedeva; Alice Kuo; Serge Yarovoi; Sergei Tkachuk; Sergei Zaitsev; Khalil Bdeir; Inna Dumler; Michael S Marks; Yelena Parfyonova; Vsevolod A Tkachuk; Abd Al-Roof Higazi; Douglas B Cines
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

Review 5.  Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy.

Authors:  Farwa Altaf; Shourong Wu; Vivi Kasim
Journal:  Front Mol Biosci       Date:  2021-05-28

6.  Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.

Authors:  Juan F Santibanez
Journal:  ISRN Dermatol       Date:  2013-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.